Correlation Between Veracyte and Biora Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Biora Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Biora Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Biora Therapeutics, you can compare the effects of market volatilities on Veracyte and Biora Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Biora Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Biora Therapeutics.

Diversification Opportunities for Veracyte and Biora Therapeutics

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Veracyte and Biora is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Biora Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biora Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Biora Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biora Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Biora Therapeutics go up and down completely randomly.

Pair Corralation between Veracyte and Biora Therapeutics

Given the investment horizon of 90 days Veracyte is expected to generate 0.51 times more return on investment than Biora Therapeutics. However, Veracyte is 1.94 times less risky than Biora Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Biora Therapeutics is currently generating about -0.28 per unit of risk. If you would invest  3,498  in Veracyte on September 4, 2024 and sell it today you would earn a total of  914.00  from holding Veracyte or generate 26.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Biora Therapeutics

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Biora Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biora Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Veracyte and Biora Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Biora Therapeutics

The main advantage of trading using opposite Veracyte and Biora Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Biora Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biora Therapeutics will offset losses from the drop in Biora Therapeutics' long position.
The idea behind Veracyte and Biora Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device